TradingAgents AISign inGet started
All stock profiles
GNLXNASDAQHealthcare

GENELUX CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$2.08

-0.95%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze GNLX free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-17.5%

3 months

-30.2%

6 months

-24.1%

1 year

-73.9%

Year to date

-52.3%

52-week range

$1.91 – $8.24

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$94.1M

P/E

-2.6

P/B

5.8

P/S

—

Revenue

$0

Net income

-$35.6M

Diluted EPS

-0.86

Gross margin

—

Net margin

—

Return on equity

-205.80%

Total debt

$2.42M

Cash

$9.18M

Free cash flow

-$28.68M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$9.47M——-$7.98M
Mar 31, 2026$0-$8.93M——-$6.98M
Dec 31, 2025$0-$9.25M——-$6.64M
Sep 30, 2025$0-$7.95M——-$7.09M
Jun 30, 2025$0-$7.46M——-$7.17M
Mar 31, 2025$0-$7.49M——-$5.47M
Dec 31, 2024$0-$8.98M——-$4.4M
Sep 30, 2024$0-$6.47M——-$5.78M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent GNLX news

All market news

No ticker-linked stories are in the current archive.